At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02157 LEPU BIO-B
Market Closed 11-22 16:08:13
2.810
-0.240
-7.87%
High3.130
Low2.780
Vol4.48M
Open3.130
D1 Closing3.050
Amplitude11.48%
Mkt Cap4.81B
Tradable Cap4.65B
Total Shares1.71B
T/O13.00M
T/O Rate0.27%
Tradable Shares1.66B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BUZZ-Lepu Biopharma jumps most in 12 weeks on progress of cancer drug application
LePU Biopharma Co Ltd is a China-based biopharmaceutical company focused on tumor treatment. The Company mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The Company's products are sold at home and abroad.